Current Immunotherapeutic Strategies in Breast Cancer
- 31 October 2007
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 16 (4), 841-860
- https://doi.org/10.1016/j.soc.2007.07.008
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Harnessing the immune system to treat cancerJournal of Clinical Investigation, 2007
- Getting Melanoma Cells to Stimulate With FrequencyJournal of Clinical Oncology, 2005
- A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing MalignanciesClinical Cancer Research, 2004
- Cellular Immunity in Breast Cancer Patients Completing Taxane TreatmentClinical Cancer Research, 2004
- Effect of Dose on Immune Response in Patients Vaccinated With an HER-2/neu Intracellular Domain Protein—Based VaccineJournal of Clinical Oncology, 2004
- Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological ResultsHuman Gene Therapy, 2003
- Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cellsEuropean Journal of Immunology, 2001
- Interleukin-12 Overcomes Paclitaxel-Mediated Suppression of T-Cell ProliferationImmunopharmacology and Immunotoxicology, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997